시장보고서
상품코드
1828883

방사성 의약품 시장 분석 및 예측(-2034년) : 유형, 제품, 용도, 최종 사용자, 기술, 형태, 서비스, 모드, 단계별

Radiopharmaceuticals Market Analysis and Forecast to 2034: Type, Product, Application, End User, Technology, Form, Services, Mode, Stage

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 325 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

방사성 의약품 시장은 2024년 184억 달러에서 2034년에는 720억 달러로 확대되며 약 14.6%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 방사성 의약품 시장에는 진단 및 치료를 위한 핵의학에서 사용되는 화합물이 포함되어 있으며 방사성 동위원소와 약물이 통합되어 있습니다. 이러한 약물은 특정 장기, 조직, 세포 수용체를 표적으로 하여 암과 같은 질병의 정확한 영상화 및 치료를 가능하게 합니다. 의료용 영상 진단의 진보, 만성 질환 증가, 방사성 표지 기술의 혁신이 시장을 견인해 진단·치료 용도의 성장을 가속하고 있습니다.

방사성 의약품 시장은 핵의학의 진보와 표적 치료 수요 증가에 힘입어 견조한 확대를 계속하고 있습니다. 진단 분야는 특히 종양학 및 신경학 응용 분야에 필수적인 PET 추적자의 이점으로 업적을 이끌고 있습니다. SPECT 트레이서가 이어지지만, 이것은 심장 병학과 뼈 이미징의 지속적인 관련성을 반영합니다. 치료 분야에서는 방사성 표지 단일클론항체가 암세포를 표적으로 하는 특이성에 의해 기세를 늘리고 있습니다. 펩티드 수용체 방사성 핵종 치료(PRRT) 또한 신경 내분비 종양의 유망한 치료법으로 상승하고 있습니다. 시장은 영상 진단과 치료 능력을 결합하고 개인화된 의료 접근법을 강화하는 테라노스틱스로의 전환을 목격하고 있습니다. 새로운 방사성 동위원소의 개발과 방사화학의 진보가 시장 성장을 더욱 뒷받침하고 있습니다. 제약기업과 연구기관의 전략적 제휴와 협력관계가 혁신을 촉진하고 임상시험을 가속화하고 있습니다. R&D 투자 증가와 방사성 의약품에 대한 규제 당국의 지원은 시장 기세를 유지할 것으로 예측됩니다.

시장 세분화
유형 진단용 방사성 의약품, 치료용 방사성 의약품
제품 테크네튬-99m, 요오드-131, 플루오로데옥시글루코스(FDG), 갈륨-68, 루테튬-177, 이트륨-90, 라듐-223, 사마륨-153, 스트론튬-89
응용 분야 종양학, 심장학, 신경학, 내분비학, 위장관학, 신장학, 정형외과
최종 사용자 병원, 진단센터, 외래 수술 센터(ASC), 학술 및 연구 기관, 제약 및 생명공학 기업
기술 사이클로트론, 원자로, 선형 가속기
형태 액체, 고체, 기체
서비스 방사성 동위원소 생산, 방사성 의약품 제조, 품질 관리 및 시험, 규제 준수, 물류 및 유통
모드 내부 수행, 외부 위탁
단계 전임상, 임상, 상업화

시장 현황

방사성 의약품 시장은 역동적인 시장 점유율 분포, 경쟁적인 가격 전략, 신제품 상시의 급증을 특징으로 합니다. 주요 기업은 제품 포트폴리오를 강화하기 위해 혁신적인 기술에 주력하고 있습니다. 시장은 정밀의료로의 전환을 목격하고 있으며, 타겟을 좁힌 방사성 의약품 치료 수요를 견인하고 있습니다. 북미는 연구개발에 많은 투자를 하고 있으며 여전히 우위를 유지하고 있습니다. 유럽과 아시아태평양도 의료비 증가와 기술 진보에 힘입어 큰 성장을 이루고 있습니다. 경쟁 벤치마킹은 전략적 제휴와 합병이 눈에 띄는 상황을 드러냈습니다. 기업은 파트너십을 활용하여 세계 비즈니스 전개와 제품 제공 강화를 도모하고 있습니다. 규제의 영향은 매우 중요한 역할을 하고 있으며, 엄격한 지침이 시장 진입과 규정 준수에 영향을 미치고 있습니다. 미국 FDA와 유럽 의약청은 시장의 역학을 형성하는 주요 규제 기관입니다. 시장이 발전함에 따라 안전과 효능에 중점을 둔 기술 혁신이 계속 추진되어 이해 관계자에게 유리한 기회를 제공합니다.

주요 동향 및 성장 촉진요인 :

방사성 의약품 시장은 핵 의학과 개인화 건강 관리의 발전으로 강력한 성장을 이루고 있습니다. 주요 동향에는 정밀의료가 주목받게 된 암의 진단과 치료에서 방사성 의약품의 사용 증가가 포함됩니다. 특정 암종을 표적으로 한 신규 방사성 의약품의 개발로 치료 효과와 환자의 결과가 향상되고 있습니다. 또한, 만성 질환 증가와 노화는 영상 진단 수요를 촉진하고 있습니다. 하이브리드 이미징 시스템과 같은 기술 혁신이 시장 확대를 더욱 강화하고 있습니다. 규제 당국의 지원과 유리한 상환 정책은 방사성 의약품의 연구 개발에 대한 투자를 촉진하고 있습니다. 또한 제약회사와 연구기관의 전략적 제휴가 혁신을 촉진하고 있습니다. 헬스케어의 인프라가 정비되고 있는 신흥 시장에도 기회는 많습니다. 제품 포트폴리오와 지리적 도달범위 확대에 주력하는 기업은 이러한 추세를 활용할 수 있는 이점이 있습니다. 방사성 의약품 시장은 과학적 진보의 지속과 건강 관리 수요 증가에 견인되어 지속적인 성장이 예상됩니다.

성장 억제요인 및 도전 :

방사성 의약품 시장에는 몇 가지 엄격한 억제요인 및 도전이 있습니다. 중요한 과제 중 하나는 규제 상황의 엄격함입니다. 규제기관은 엄격한 시험 및 승인 과정을 부과하므로 신제품의 도입이 지연될 수 있습니다. 이것은 중소기업의 진입 장벽이 되어 혁신을 저해합니다. 또 다른 과제는 방사성 의약품 제조에 드는 비용이 높다는 것입니다. 특수한 시설과 설비가 필요하기 때문에 운영비가 부담하여 시장 확대가 제한됩니다. 또한 많은 방사성 의약품은 반감기가 짧기 때문에 적시 공급을 보장하기 위해 견고한 공급망이 필요하며 물류가 더욱 복잡해집니다. 시장은 또한 숙련된 전문가의 부족에 직면하고 있습니다. 방사성 의약품의 안전한 취급과 적용에는 핵의학의 전문 지식이 필수적이지만, 유자격자의 수는 제한되어 있습니다. 또한 일반 시민의 방사선에 대한 인식과 공포심이 장애가 되고 있습니다. 안전성에 대한 오해는 방사성 의약품에 의한 치료에 대한 소극적인 자세를 초래하여 시장 성장에 영향을 미칩니다.

주요 기업

Advanced Accelerator Applications, Blue Earth Diagnostics, ITM Isotope Technologies Munich, Lantheus Medical Imaging, Jubilant Radiopharma, Curium, Telix Pharmaceuticals, Bayer Radiopharma, NorthStar Medical Radioisotopes, Eckert &Ziegler, Sofie Biosciences Imaging, Radiomedix, ImaginAb

목차

제1장 방사성 의약품 시장 개요

  • 조사 목적
  • 방사성 의약품 시장 정의와 조사 범위
  • 보고서 한계 사항
  • 조사 대상 연도 및 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 방사성 의약품 시장 전망

  • 방사성 의약품 시장 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 방사성 의약품 시장 전략

  • 상위 시장 분석
  • 수급 분석
  • 소비자의 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 방사성 의약품 시장 규모

  • 방사성 의약품 시장 규모 : 금액별
  • 방사성 의약품 시장 규모 : 수량별

제7장 방사성 의약품 시장 : 유형별

  • 시장 개요
  • 진단용 방사성 의약품
  • 치료용 방사성 의약품
  • 기타

제8장 방사성 의약품 시장 : 제품별

  • 시장 개요
  • 테크네튬-99m
  • 요오드 131
  • 플루오로데옥시글루코스(FDG)
  • 갈륨-68
  • 루테튬-177
  • 이트륨-90
  • 라듐-223
  • 사마륨-153
  • 스트론튬-89
  • 기타

제9장 방사성 의약품 시장 : 용도별

  • 시장 개요
  • 종양학
  • 심장학
  • 신경학
  • 내분비학
  • 위장관학
  • 신장학
  • 정형외과
  • 기타

제10장 방사성 의약품 시장 : 최종 사용자별

  • 시장 개요
  • 병원
  • 진단센터
  • 외래 수술 센터(ASC)
  • 학술 및 연구 기관
  • 제약 및 생명공학 기업
  • 기타

제11장 방사성 의약품 시장 : 기술별

  • 시장 개요
  • 사이클로트론
  • 원자로
  • 선형 가속기
  • 기타

제12장 방사성 의약품 시장 : 형태별

  • 시장 개요
  • 액체
  • 고체
  • 기체
  • 기타

제13장 방사성 의약품 시장 : 서비스별

  • 시장 개요
  • 방사성 동위원소 생산
  • 방사성 의약품 제조
  • 품질 관리 및 시험
  • 규제 준수
  • 물류 및 유통
  • 기타

제14장 방사성 의약품 시장 : 모드별

  • 시장 개요
  • 내부 수행
  • 외부 위탁
  • 기타

제15장 방사성 의약품 시장 : 단계별

  • 시장 개요
  • 전임상
  • 임상
  • 상업화
  • 기타

제16장 방사성 의약품 시장 : 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 기타 중동 및 아프리카

제17장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략의 벤치마킹

제18장 기업 프로파일

  • Advanced Accelerator Applications
  • Blue Earth Diagnostics
  • ITM Isotope Technologies Munich
  • Lantheus Medical Imaging
  • Jubilant Radiopharma
  • Curium
  • Telix Pharmaceuticals
  • Bayer Radiopharma
  • NorthStar Medical Radioisotopes
  • Eckert & Ziegler
  • Sofie Biosciences
  • Cardinal Health Radiopharmacy
  • Isotopia Molecular Imaging
  • Radiomedix
  • ImaginAb
KTH 25.10.14

Radiopharmaceuticals Market is anticipated to expand from $18.4 billion in 2024 to $72 billion by 2034, growing at a CAGR of approximately 14.6%. The Radiopharmaceuticals Market encompasses compounds used in nuclear medicine for diagnosis and therapy, integrating radioactive isotopes with pharmaceutical agents. These agents target specific organs, tissues, or cellular receptors, enabling precise imaging and treatment of diseases like cancer. The market is driven by advancements in medical imaging, increasing prevalence of chronic diseases, and innovations in radiolabeling techniques, fostering growth in diagnostic and therapeutic applications.

The Radiopharmaceuticals Market is experiencing robust expansion, fueled by advancements in nuclear medicine and increasing demand for targeted therapies. The diagnostic segment leads in performance, particularly with the dominance of PET tracers, which are essential in oncology and neurology applications. SPECT tracers follow, reflecting their continued relevance in cardiology and bone imaging. In the therapeutic segment, radiolabeled monoclonal antibodies are gaining momentum, driven by their specificity in targeting cancer cells. Peptide receptor radionuclide therapy (PRRT) is also emerging as a promising treatment for neuroendocrine tumors. The market is witnessing a shift towards theranostics, combining diagnostic imaging and therapeutic capabilities, enhancing personalized medicine approaches. The development of novel radioisotopes and advancements in radiochemistry are further propelling market growth. Strategic partnerships and collaborations among pharmaceutical companies and research institutions are fostering innovation and accelerating clinical trials. Increasing investments in R&D and regulatory support for radiopharmaceuticals are expected to sustain market momentum.

Market Segmentation
TypeDiagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals
ProductTechnetium-99m, Iodine-131, Fluorodeoxyglucose (FDG), Gallium-68, Lutetium-177, Yttrium-90, Radium-223, Samarium-153, Strontium-89
ApplicationOncology, Cardiology, Neurology, Endocrinology, Gastroenterology, Nephrology, Orthopedics
End UserHospitals, Diagnostic Centers, Ambulatory Surgical Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies
TechnologyCyclotron, Nuclear Reactor, Linear Accelerator
FormLiquid, Solid, Gaseous
ServicesRadioisotope Production, Radiopharmaceutical Manufacturing, Quality Control and Testing, Regulatory Compliance, Logistics and Distribution
ModeIn-house, Outsourced
StagePreclinical, Clinical, Commercial

Market Snapshot:

The radiopharmaceuticals market is characterized by dynamic market share distribution, competitive pricing strategies, and a surge in new product launches. Key players are focusing on innovative technologies to enhance their product portfolios. The market is witnessing a shift towards precision medicine, driving demand for targeted radiopharmaceutical therapies. North America remains a dominant player, with substantial investments in research and development. Europe and Asia-Pacific are also experiencing significant growth, propelled by increasing healthcare expenditure and technological advancements. Competition benchmarking reveals a landscape marked by strategic collaborations and mergers. Companies are leveraging partnerships to expand their global footprint and enhance product offerings. Regulatory influences play a pivotal role, with stringent guidelines impacting market entry and compliance. The U.S. FDA and the European Medicines Agency are key regulatory bodies shaping the market dynamics. As the market evolves, the focus on safety and efficacy continues to drive innovation, offering lucrative opportunities for stakeholders.

Geographical Overview:

The radiopharmaceuticals market is experiencing notable growth across various regions, each presenting unique opportunities. North America remains a dominant force, driven by advanced healthcare infrastructure and substantial investments in nuclear medicine. The region's focus on precision medicine and increasing prevalence of chronic diseases further bolster market expansion. Europe follows, with strong research and development initiatives and regulatory support enhancing market dynamics. The emphasis on innovative cancer therapies and diagnostics contributes to the region's growth. In Asia Pacific, the market is expanding rapidly, fueled by rising healthcare expenditures and increasing awareness of nuclear medicine's benefits. Emerging economies like China and India are pivotal in this growth trajectory. Latin America and the Middle East & Africa are emerging markets with significant potential. Latin America is witnessing increased adoption of radiopharmaceuticals, driven by improving healthcare infrastructure. Meanwhile, the Middle East & Africa are recognizing the importance of nuclear medicine in advancing healthcare outcomes, presenting lucrative opportunities for market players.

Key Trends and Drivers:

The radiopharmaceuticals market is experiencing robust growth driven by advancements in nuclear medicine and personalized healthcare. Key trends include the increasing use of radiopharmaceuticals in cancer diagnosis and treatment, where precision medicine is gaining prominence. The development of novel radiopharmaceuticals targeting specific cancer types is enhancing treatment efficacy and patient outcomes. Moreover, the rising prevalence of chronic diseases and an aging population are fueling demand for diagnostic imaging. Technological innovations, such as hybrid imaging systems, are further propelling market expansion. Regulatory support and favorable reimbursement policies are encouraging investment in radiopharmaceutical research and development. The market is also witnessing strategic collaborations between pharmaceutical companies and research institutions, fostering innovation. Opportunities abound in emerging markets, where healthcare infrastructure is improving. Companies that focus on expanding their product portfolio and geographic reach are well-positioned to capitalize on these trends. The radiopharmaceuticals market is poised for sustained growth, driven by ongoing scientific advancements and increasing healthcare demands.

Restraints and Challenges:

The radiopharmaceuticals market encounters several formidable restraints and challenges. One significant challenge is the stringent regulatory landscape. Regulatory bodies impose rigorous testing and approval processes, which can delay the introduction of new products. This creates a barrier to entry for smaller companies and stifles innovation. Another challenge is the high cost associated with radiopharmaceutical production. The need for specialized facilities and equipment increases operational expenses, limiting market expansion. Additionally, the short half-life of many radiopharmaceuticals necessitates a robust supply chain to ensure timely delivery, further complicating logistics. The market also faces a shortage of skilled professionals. Expertise in nuclear medicine is essential for the safe handling and application of radiopharmaceuticals, yet there is a limited pool of qualified personnel. Furthermore, public perception and fear of radiation pose hurdles. Misunderstandings about safety can lead to reluctance in adopting radiopharmaceutical treatments, affecting market growth.

Key Players:

Advanced Accelerator Applications, Blue Earth Diagnostics, ITM Isotope Technologies Munich, Lantheus Medical Imaging, Jubilant Radiopharma, Curium, Telix Pharmaceuticals, Bayer Radiopharma, NorthStar Medical Radioisotopes, Eckert & Ziegler, Sofie Biosciences, Cardinal Health Radiopharmacy, Isotopia Molecular Imaging, Radiomedix, ImaginAb

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Radiopharmaceuticals Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Radiopharmaceuticals Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Application
  • 2.6 Key Highlights of the Market, by End User
  • 2.7 Key Highlights of the Market, by Technology
  • 2.8 Key Highlights of the Market, by Form
  • 2.9 Key Highlights of the Market, by Services
  • 2.10 Key Highlights of the Market, by Mode
  • 2.11 Key Highlights of the Market, by Stage
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Application
  • 3.5 Market Attractiveness Analysis, by End User
  • 3.6 Market Attractiveness Analysis, by Technology
  • 3.7 Market Attractiveness Analysis, by Form
  • 3.8 Market Attractiveness Analysis, by Services
  • 3.9 Market Attractiveness Analysis, by Mode
  • 3.10 Market Attractiveness Analysis, by Stage
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Radiopharmaceuticals Market Outlook

  • 4.1 Radiopharmaceuticals Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Radiopharmaceuticals Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Radiopharmaceuticals Market Size

  • 6.1 Radiopharmaceuticals Market Size, by Value
  • 6.2 Radiopharmaceuticals Market Size, by Volume

7: Radiopharmaceuticals Market, by Type

  • 7.1 Market Overview
  • 7.2 Diagnostic Radiopharmaceuticals
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Therapeutic Radiopharmaceuticals
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Others
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region

8: Radiopharmaceuticals Market, by Product

  • 8.1 Market Overview
  • 8.2 Technetium-99m
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Iodine-131
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Fluorodeoxyglucose (FDG)
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Gallium-68
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Lutetium-177
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Yttrium-90
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Radium-223
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Samarium-153
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region
  • 8.10 Strontium-89
    • 8.10.1 Key Market Trends & Opportunity Analysis
    • 8.10.2 Market Size and Forecast, by Region
  • 8.11 Others
    • 8.11.1 Key Market Trends & Opportunity Analysis
    • 8.11.2 Market Size and Forecast, by Region

9: Radiopharmaceuticals Market, by Application

  • 9.1 Market Overview
  • 9.2 Oncology
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Cardiology
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Neurology
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Endocrinology
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Gastroenterology
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Nephrology
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Orthopedics
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region
  • 9.9 Others
    • 9.9.1 Key Market Trends & Opportunity Analysis
    • 9.9.2 Market Size and Forecast, by Region

10: Radiopharmaceuticals Market, by End User

  • 10.1 Market Overview
  • 10.2 Hospitals
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Diagnostic Centers
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Ambulatory Surgical Centers
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Academic and Research Institutes
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Pharmaceutical and Biotechnology Companies
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Others
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region

11: Radiopharmaceuticals Market, by Technology

  • 11.1 Market Overview
  • 11.2 Cyclotron
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Nuclear Reactor
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Linear Accelerator
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Others
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region

12: Radiopharmaceuticals Market, by Form

  • 12.1 Market Overview
  • 12.2 Liquid
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Solid
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Gaseous
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: Radiopharmaceuticals Market, by Services

  • 13.1 Market Overview
  • 13.2 Radioisotope Production
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Radiopharmaceutical Manufacturing
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Quality Control and Testing
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Regulatory Compliance
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Logistics and Distribution
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region
  • 13.7 Others
    • 13.7.1 Key Market Trends & Opportunity Analysis
    • 13.7.2 Market Size and Forecast, by Region

14: Radiopharmaceuticals Market, by Mode

  • 14.1 Market Overview
  • 14.2 In-house
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Outsourced
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: Radiopharmaceuticals Market, by Stage

  • 15.1 Market Overview
  • 15.2 Preclinical
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Clinical
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Commercial
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Radiopharmaceuticals Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Application
    • 16.2.5 North America Market Size and Forecast, by End User
    • 16.2.6 North America Market Size and Forecast, by Technology
    • 16.2.7 North America Market Size and Forecast, by Form
    • 16.2.8 North America Market Size and Forecast, by Services
    • 16.2.9 North America Market Size and Forecast, by Mode
    • 16.2.10 North America Market Size and Forecast, by Stage
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Application
      • 16.2.9.4 United States Market Size and Forecast, by End User
      • 16.2.9.5 United States Market Size and Forecast, by Technology
      • 16.2.9.6 United States Market Size and Forecast, by Form
      • 16.2.9.7 United States Market Size and Forecast, by Services
      • 16.2.9.8 United States Market Size and Forecast, by Mode
      • 16.2.9.9 United States Market Size and Forecast, by Stage
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Application
      • 16.2.10.4 Canada Market Size and Forecast, by End User
      • 16.2.10.5 Canada Market Size and Forecast, by Technology
      • 16.2.10.6 Canada Market Size and Forecast, by Form
      • 16.2.10.7 Canada Market Size and Forecast, by Services
      • 16.2.10.8 Canada Market Size and Forecast, by Mode
      • 16.2.10.9 Canada Market Size and Forecast, by Stage
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Application
    • 16.3.5 Europe Market Size and Forecast, by End User
    • 16.3.6 Europe Market Size and Forecast, by Technology
    • 16.3.7 Europe Market Size and Forecast, by Form
    • 16.3.8 Europe Market Size and Forecast, by Services
    • 16.3.9 Europe Market Size and Forecast, by Mode
    • 16.3.10 Europe Market Size and Forecast, by Stage
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.4 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Form
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Mode
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Stage
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Application
      • 16.3.10.4 Germany Market Size and Forecast, by End User
      • 16.3.10.5 Germany Market Size and Forecast, by Technology
      • 16.3.10.6 Germany Market Size and Forecast, by Form
      • 16.3.10.7 Germany Market Size and Forecast, by Services
      • 16.3.10.8 Germany Market Size and Forecast, by Mode
      • 16.3.10.9 Germany Market Size and Forecast, by Stage
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Application
      • 16.3.11.4 France Market Size and Forecast, by End User
      • 16.3.11.5 France Market Size and Forecast, by Technology
      • 16.3.11.6 France Market Size and Forecast, by Form
      • 16.3.11.7 France Market Size and Forecast, by Services
      • 16.3.11.8 France Market Size and Forecast, by Mode
      • 16.3.11.9 France Market Size and Forecast, by Stage
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Application
      • 16.3.12.4 Spain Market Size and Forecast, by End User
      • 16.3.12.5 Spain Market Size and Forecast, by Technology
      • 16.3.12.6 Spain Market Size and Forecast, by Form
      • 16.3.12.7 Spain Market Size and Forecast, by Services
      • 16.3.12.8 Spain Market Size and Forecast, by Mode
      • 16.3.12.9 Spain Market Size and Forecast, by Stage
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Application
      • 16.3.13.4 Italy Market Size and Forecast, by End User
      • 16.3.13.5 Italy Market Size and Forecast, by Technology
      • 16.3.13.6 Italy Market Size and Forecast, by Form
      • 16.3.13.7 Italy Market Size and Forecast, by Services
      • 16.3.13.8 Italy Market Size and Forecast, by Mode
      • 16.3.13.9 Italy Market Size and Forecast, by Stage
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Application
      • 16.3.14.4 Netherlands Market Size and Forecast, by End User
      • 16.3.14.5 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.6 Netherlands Market Size and Forecast, by Form
      • 16.3.14.7 Netherlands Market Size and Forecast, by Services
      • 16.3.14.8 Netherlands Market Size and Forecast, by Mode
      • 16.3.14.9 Netherlands Market Size and Forecast, by Stage
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Application
      • 16.3.15.4 Sweden Market Size and Forecast, by End User
      • 16.3.15.5 Sweden Market Size and Forecast, by Technology
      • 16.3.15.6 Sweden Market Size and Forecast, by Form
      • 16.3.15.7 Sweden Market Size and Forecast, by Services
      • 16.3.15.8 Sweden Market Size and Forecast, by Mode
      • 16.3.15.9 Sweden Market Size and Forecast, by Stage
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Application
      • 16.3.16.4 Switzerland Market Size and Forecast, by End User
      • 16.3.16.5 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.6 Switzerland Market Size and Forecast, by Form
      • 16.3.16.7 Switzerland Market Size and Forecast, by Services
      • 16.3.16.8 Switzerland Market Size and Forecast, by Mode
      • 16.3.16.9 Switzerland Market Size and Forecast, by Stage
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Application
      • 16.3.17.4 Denmark Market Size and Forecast, by End User
      • 16.3.17.5 Denmark Market Size and Forecast, by Technology
      • 16.3.17.6 Denmark Market Size and Forecast, by Form
      • 16.3.17.7 Denmark Market Size and Forecast, by Services
      • 16.3.17.8 Denmark Market Size and Forecast, by Mode
      • 16.3.17.9 Denmark Market Size and Forecast, by Stage
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Application
      • 16.3.18.4 Finland Market Size and Forecast, by End User
      • 16.3.18.5 Finland Market Size and Forecast, by Technology
      • 16.3.18.6 Finland Market Size and Forecast, by Form
      • 16.3.18.7 Finland Market Size and Forecast, by Services
      • 16.3.18.8 Finland Market Size and Forecast, by Mode
      • 16.3.18.9 Finland Market Size and Forecast, by Stage
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Application
      • 16.3.19.4 Russia Market Size and Forecast, by End User
      • 16.3.19.5 Russia Market Size and Forecast, by Technology
      • 16.3.19.6 Russia Market Size and Forecast, by Form
      • 16.3.19.7 Russia Market Size and Forecast, by Services
      • 16.3.19.8 Russia Market Size and Forecast, by Mode
      • 16.3.19.9 Russia Market Size and Forecast, by Stage
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Form
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Mode
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Stage
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.5 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Form
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Mode
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Stage
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Application
      • 16.4.9.4 China Market Size and Forecast, by End User
      • 16.4.9.5 China Market Size and Forecast, by Technology
      • 16.4.9.6 China Market Size and Forecast, by Form
      • 16.4.9.7 China Market Size and Forecast, by Services
      • 16.4.9.8 China Market Size and Forecast, by Mode
      • 16.4.9.9 China Market Size and Forecast, by Stage
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Application
      • 16.4.10.4 India Market Size and Forecast, by End User
      • 16.4.10.5 India Market Size and Forecast, by Technology
      • 16.4.10.6 India Market Size and Forecast, by Form
      • 16.4.10.7 India Market Size and Forecast, by Services
      • 16.4.10.8 India Market Size and Forecast, by Mode
      • 16.4.10.9 India Market Size and Forecast, by Stage
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Application
      • 16.4.11.4 Japan Market Size and Forecast, by End User
      • 16.4.11.5 Japan Market Size and Forecast, by Technology
      • 16.4.11.6 Japan Market Size and Forecast, by Form
      • 16.4.11.7 Japan Market Size and Forecast, by Services
      • 16.4.11.8 Japan Market Size and Forecast, by Mode
      • 16.4.11.9 Japan Market Size and Forecast, by Stage
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Application
      • 16.4.12.4 South Korea Market Size and Forecast, by End User
      • 16.4.12.5 South Korea Market Size and Forecast, by Technology
      • 16.4.12.6 South Korea Market Size and Forecast, by Form
      • 16.4.12.7 South Korea Market Size and Forecast, by Services
      • 16.4.12.8 South Korea Market Size and Forecast, by Mode
      • 16.4.12.9 South Korea Market Size and Forecast, by Stage
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Application
      • 16.4.13.4 Australia Market Size and Forecast, by End User
      • 16.4.13.5 Australia Market Size and Forecast, by Technology
      • 16.4.13.6 Australia Market Size and Forecast, by Form
      • 16.4.13.7 Australia Market Size and Forecast, by Services
      • 16.4.13.8 Australia Market Size and Forecast, by Mode
      • 16.4.13.9 Australia Market Size and Forecast, by Stage
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Application
      • 16.4.14.4 Singapore Market Size and Forecast, by End User
      • 16.4.14.5 Singapore Market Size and Forecast, by Technology
      • 16.4.14.6 Singapore Market Size and Forecast, by Form
      • 16.4.14.7 Singapore Market Size and Forecast, by Services
      • 16.4.14.8 Singapore Market Size and Forecast, by Mode
      • 16.4.14.9 Singapore Market Size and Forecast, by Stage
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Application
      • 16.4.15.4 Indonesia Market Size and Forecast, by End User
      • 16.4.15.5 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.6 Indonesia Market Size and Forecast, by Form
      • 16.4.15.7 Indonesia Market Size and Forecast, by Services
      • 16.4.15.8 Indonesia Market Size and Forecast, by Mode
      • 16.4.15.9 Indonesia Market Size and Forecast, by Stage
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Application
      • 16.4.16.4 Taiwan Market Size and Forecast, by End User
      • 16.4.16.5 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.6 Taiwan Market Size and Forecast, by Form
      • 16.4.16.7 Taiwan Market Size and Forecast, by Services
      • 16.4.16.8 Taiwan Market Size and Forecast, by Mode
      • 16.4.16.9 Taiwan Market Size and Forecast, by Stage
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Application
      • 16.4.17.4 Malaysia Market Size and Forecast, by End User
      • 16.4.17.5 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.6 Malaysia Market Size and Forecast, by Form
      • 16.4.17.7 Malaysia Market Size and Forecast, by Services
      • 16.4.17.8 Malaysia Market Size and Forecast, by Mode
      • 16.4.17.9 Malaysia Market Size and Forecast, by Stage
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Form
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Application
    • 16.5.5 Latin America Market Size and Forecast, by End User
    • 16.5.6 Latin America Market Size and Forecast, by Technology
    • 16.5.7 Latin America Market Size and Forecast, by Form
    • 16.5.8 Latin America Market Size and Forecast, by Services
    • 16.5.9 Latin America Market Size and Forecast, by Mode
    • 16.5.10 Latin America Market Size and Forecast, by Stage
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Application
      • 16.5.9.4 Brazil Market Size and Forecast, by End User
      • 16.5.9.5 Brazil Market Size and Forecast, by Technology
      • 16.5.9.6 Brazil Market Size and Forecast, by Form
      • 16.5.9.7 Brazil Market Size and Forecast, by Services
      • 16.5.9.8 Brazil Market Size and Forecast, by Mode
      • 16.5.9.9 Brazil Market Size and Forecast, by Stage
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Application
      • 16.5.10.4 Mexico Market Size and Forecast, by End User
      • 16.5.10.5 Mexico Market Size and Forecast, by Technology
      • 16.5.10.6 Mexico Market Size and Forecast, by Form
      • 16.5.10.7 Mexico Market Size and Forecast, by Services
      • 16.5.10.8 Mexico Market Size and Forecast, by Mode
      • 16.5.10.9 Mexico Market Size and Forecast, by Stage
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Application
      • 16.5.11.4 Argentina Market Size and Forecast, by End User
      • 16.5.11.5 Argentina Market Size and Forecast, by Technology
      • 16.5.11.6 Argentina Market Size and Forecast, by Form
      • 16.5.11.7 Argentina Market Size and Forecast, by Services
      • 16.5.11.8 Argentina Market Size and Forecast, by Mode
      • 16.5.11.9 Argentina Market Size and Forecast, by Stage
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Form
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Mode
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Stage
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.5 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Form
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Mode
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Stage
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Form
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Mode
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Stage
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Application
      • 16.6.10.4 UAE Market Size and Forecast, by End User
      • 16.6.10.5 UAE Market Size and Forecast, by Technology
      • 16.6.10.6 UAE Market Size and Forecast, by Form
      • 16.6.10.7 UAE Market Size and Forecast, by Services
      • 16.6.10.8 UAE Market Size and Forecast, by Mode
      • 16.6.10.9 UAE Market Size and Forecast, by Stage
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Application
      • 16.6.11.4 South Africa Market Size and Forecast, by End User
      • 16.6.11.5 South Africa Market Size and Forecast, by Technology
      • 16.6.11.6 South Africa Market Size and Forecast, by Form
      • 16.6.11.7 South Africa Market Size and Forecast, by Services
      • 16.6.11.8 South Africa Market Size and Forecast, by Mode
      • 16.6.11.9 South Africa Market Size and Forecast, by Stage
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Form
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Mode
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Stage
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Advanced Accelerator Applications
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Blue Earth Diagnostics
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 ITM Isotope Technologies Munich
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Lantheus Medical Imaging
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Jubilant Radiopharma
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Curium
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Telix Pharmaceuticals
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Bayer Radiopharma
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 NorthStar Medical Radioisotopes
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Eckert & Ziegler
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Sofie Biosciences
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Cardinal Health Radiopharmacy
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Isotopia Molecular Imaging
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Radiomedix
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 ImaginAb
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제